410 related articles for article (PubMed ID: 25850749)
1. Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence?
Taddei S
Am J Cardiovasc Drugs; 2015 Jun; 15(3):185-94. PubMed ID: 25850749
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?
Riva N; Lip GY
Curr Pharm Des; 2013; 19(21):3753-65. PubMed ID: 23286431
[TBL] [Abstract][Full Text] [Related]
4. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
5. The ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertension.
Meurin P
Am J Cardiovasc Drugs; 2006; 6(5):327-34. PubMed ID: 17083267
[TBL] [Abstract][Full Text] [Related]
6. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
Reboldi G; Gentile G; Angeli F; Verdecchia P
Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778
[TBL] [Abstract][Full Text] [Related]
7. Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE inhibitor.
Elliott WJ; Polascik TB; Murphy MB
J Hum Hypertens; 1990 Dec; 4(6):717-23. PubMed ID: 2096214
[TBL] [Abstract][Full Text] [Related]
8. Fixed-dose combination antihypertensives and reduction in target organ damage: are they all the same?
Smith DH
Am J Cardiovasc Drugs; 2007; 7(6):413-22. PubMed ID: 18076208
[TBL] [Abstract][Full Text] [Related]
9. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
10. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
11. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy for the management of hypertension: A review of the evidence.
Sood N; Reinhart KM; Baker WL
Am J Health Syst Pharm; 2010 Jun; 67(11):885-94. PubMed ID: 20484210
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
14. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
Chazova IE; Martynyuk TV
Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
[TBL] [Abstract][Full Text] [Related]
15. [Arterial Hypertension - when are which combination therapies useful?].
Brenner R; Rimoldi SF; Rexhaj E; Allemann Y
Ther Umsch; 2012 May; 69(5):305-13. PubMed ID: 22547363
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy for hypertension.
Kaplan NM
Nat Rev Cardiol; 2009 Apr; 6(4):270-1. PubMed ID: 19352329
[TBL] [Abstract][Full Text] [Related]
17. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
18. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.
Sica DA
Drugs; 2002; 62(3):443-62. PubMed ID: 11827559
[TBL] [Abstract][Full Text] [Related]
19. RAS inhibitors' dose-dependent efficacy: myth or reality?
Taddei S
Curr Med Res Opin; 2015; 31(7):1245-56. PubMed ID: 25985327
[TBL] [Abstract][Full Text] [Related]
20. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
Thomas GN; Chan P; Tomlinson B
Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
